Macroprolactinemia in hyperprolactinemic infertile women

Endocrine

Volumn 44, Issue 3, 2013, Pages 750-755

  Thirunavakkarasu, Krithika ^a   Dutta, Pinaki ^a   Sridhar, Subbiah ^a   Dhaliwal, Lakhbir ^a   Prashad, G R V ^a   Gainder, Shalini ^a   Sachdeva, Naresh ^a   Bhansali, Anil ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Galactorrhea; Hyperprolactinemia; Infertility; Macroprolactin

Indexed keywords

MACROGOL; MACROPROLACTIN; PROLACTIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENDOCRINE DISEASE; FEMALE; FEMALE INFERTILITY; GALACTORRHEA; HUMAN; HYPERPROLACTINEMIA; MACROPROLACTINEMIA; MAJOR CLINICAL STUDY; MICROADENOMA; OLIGOMENORRHEA; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SCREENING TEST; YOUNG ADULT;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERPROLACTINEMIA; INFERTILITY, FEMALE; PROLACTIN;

EID: 84890799865     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-013-9925-y     Document Type: Article

References (24)

1. T. Mancini, F.F. Casanueva, A. Giustina, Hyperprolactinemia and prolactinomas. Endocrinol. Metab. Clin. North Am. 37, 67-99 (2008)
2. J.V. Kredentser, C.F. Hoskins, J.Z. Scott, Hyperprolactinemia - a significant factor in female infertility. Am. J. Obstet. Gynecol. 139, 264-267 (1981)
3. G.S. Wand, Diagnosis and management of hyperprolactinemia. Endocrinologist 13(1), 52-57 (2003)
4. H.K. Suh, A.G. Frantz, Size heterogeneity of human prolactin in plasma and pituitary extracts. J. Clin. Endocrinol. Metabol. 39, 928-935 (1974)
5. J.B. Josimovich, M.A. Lavenhar, M.M. Devanesan, H.J. Sesta, S.A. Wilchins, A.C. Smith, Heterogeneous distribution of serum prolactin values in apparently healthy young women, and the effects of oral contraceptive medication. Fertil. Steril. 47, 785-791 (1987)
6. V. Leite, H. Cosby, L.G. Sobrinho, M.A. Fresnoza, M.A. Santos, H.G. Friesen, Characterization of big, big prolactin in patients with hyperprolactinemia. Clin Endocrinol (Oxf) 37, 365-372 (1992)
7. F. Donadio, A. Barbieri, R. Angioni, G. Mantovani, P. Beck-Peccoz, A. Spada, A.G. Lania, Patients with macroprolactinaemia: clinical and radiological features. Eur. J. Clin. Invest. 37, 552-557 (2007)
8. M.D. Bronstein, Editorial: is macroprolactinemia just a diagnostic pitfall? Endocrine 41, 169-170 (2012)
9. T.P. Smith, A.M. Suliman, M.N. Fahie-Wilson et al., Gross variability in the detection of prolactin in sera containing big prolactin (macroprolactin) by commercial immunoassays. J. Clin. Endocrinol. Metabol. 87, 5410-5415 (2002)
10. J.G.H. Vieira, T.T. Tachibana, L.H. Obara, R.M.B. Maciel, Extensive experience and validation of polyethylene glycol precipitation as a screening method for macroprolactinemia. Clin. Chem. 44, 1758-1759 (1998)
11. A. Olukoga, J. Kane, Macroprolactinaemia: validation and application of the polyethylene glycol precipitation test and clinical characterization of the condition. Clin Endocrinol (Oxf) 51, 119-126 (1999)
12. M. Fahie-Wilson, P. Brunsden, J. Surrey, A. Everitt, Macroprolactin and the Roche Elecsys prolactin assay: characteristics of the reaction and detection by precipitation with polyethylene glycol. Clin. Chem. 46, 1993-1995 (2000)
13. M.N. Fahie-Wilson, J.A. Ahlquist, A.R. Ellis, Three decades of clinical follow-up in 271 women with hyperprolactinaemia; macroprolactinaemia should be considered. Clin. Endocrinol. 64, 226 (2006)
14. S. Isik, D. Berker, Y.A. Tutuncu, U. Ozuguz, F. Gokay, S. Guler et al., Clinical and radiological findings in macroprolactinemia. Endocrine 41, 327-333 (2012)
15. H. Leslie, C. Courtney, P. Bell et al., A laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method. J. Clin. Endocrinol. Metab. 86, 2743-2746 (2001)
16. Practice Committee of the American Society for Reproductive Medicine, Definitions of infertility and recurrent pregnancy loss. Fertil Steril 90, S60 (2008)
17. N. Hattori, C. Inagaki, Anti-prolactin (PRL) autoantibodies cause asymptomatic hyperprolactinemia: bioassay and clearance studies of PRL-immunoglobulin G complex. J. Clin. Endocrinol. Metab. 82, 3107-3110 (1997)
18. M. Fahie-Wilson, S. Soule, Macroprolactinaemia: contribution to hyperprolactinaemia in a district general hospital and evaluation of a screening test based on precipitation with polyethylene glycol. Ann. Clin. Biochem. 34, 252-258 (1997)
19. A. Alfonso, K.I. Rieniets, R.A. Vigersky, Incidence and clinical significance of elevated macroprolactin levels in patients with hyperprolactinemia. Endocr Pract 12, 275-280 (2006)
20. S. Vallette-Kasic, I. Morange-Ramos, A. Selim et al., Macroprolactinemias revisited: a study on 106 patients. J. Clin. Endocrinol. Metab. 587, 581-588 (2002)
21. G. Tamer, A. Telci, M. Mert, A.K. Uzum, F. Aral, F. Alagol, Prevalence of pituitary adenomas in macroprolactinemic patients may be higher than it is presumed. Endocrine 41, 138-143 (2012)
22. T. Bjoro, L. Morkrid, R. Wergeland et al., Frequency of hyperprolactinemia due to large molecular weight prolactin (150-170 kD PRL). Scand. J. Clin. Lab. Invest. 55, 139-147 (1995)
23. N. Hattori, T. Ishihara, K. Ikekubo, K. Moridera, M. Hino, H. Kurahachi, Autoantibody to human prolactin in patients with idiopathic hyperprolactinemia. J. Clin. Endocrinol. Metab. 75, 1226-1229 (1992)
24. F.F. Casanueva, M.E. Molitch, J.A. Schlechte et al., Guidelines of the pituitary society for the diagnosis and management of prolactinomas. Clin Endocrinol (oxf) 65, 265-273 (2006)